<?xml version='1.0' encoding='iso-8859-1'?>
<PASBIO>
	<framesest>
		<predicate lemma="result">
			<roleset id="result.01" name="" wordnet="2">
				<roles>
					<role n="0" descr="Theme, prior condition &#10;"/>
					<role n="1" descr="Goal, end condition&#10;"/>
				</roles>
				<example src="EGRAM" no="0">
					<text>a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors that can result in a Clr phenotype is conferred by an activated mutation of egl-15 or by a mutation of lf clr-1.</text>
					<arg n="0">a SOS-1 role in the signaling mediated by FGFR during the developmental signaling of FGFL-15 hyperactive receptors</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="0">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor that can result in a Clr phenotype is conferred by an activated egl-15 mutation or lf clr-1.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="1">
					<text>A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling that resulted in a Clr phenotype is conferred by an activated mutation of egl-15 or a lf clr-1.</text>
					<arg n="0">A role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="1">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development that has resulted in a Clr phenotype is conferred by an activated egl-15 or lf clr-1 mutation.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="2">
					<text>a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors that has the ability to result in a Clr phenotype is conferred by an activated mutation of egl-15 or lf clr-1.</text>
					<arg n="0">a SOS-1 role in the signaling mediated by FGFR during the hyperactive developmental signaling of FGF-15 receptors</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="2">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor that has the ability to result in a Clr phenotype is conferred by an activated egl-15 mutation or lf clr-1.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="3">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor that is capable of resulting in a Clr phenotype is conferred by an activated egl-15 mutation or lf clr-1.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="3">
					<text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors is able to result in a Clr phenotype is conferred by an activated mutation of egl-15 or by a lf clr-1 mutation.</text>
					<arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 FGF receptors</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="4">
					<text>a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling which may have resulted in a Clr phenotype is conferred by an activated mutation of egl-15 or a lf clr-1.</text>
					<arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyertactive EGL-15 FGF receptor signaling</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="4">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor that may have resulted in a Clr phenotype is conferred by an activated egl-15 mutation or lf clr-1.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the hyperactive development EGL-15 FGF signaling receptor</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="5">
					<text>a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF that resulted in a Clr phenotype is conferred by an activated mutation of egl-15 or lf clr-1.</text>
					<arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the hyperactive signaling receptor EGL-15 FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="5">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor that resulted in a Clr phenotype is conferred by an activated egl-15 mutation or lf clr-1.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF signaling receptor</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="6">
					<text>a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF results in a Clr phenotype results conferred by an activated mutation egl-15 or lf clr-1.</text>
					<arg n="0">a role for SOS-1 in FGFR-mediated signaling during the development of hyperactive signaling receptors EGL-15 FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="6">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development results in a Clr phenotype is conferred by an activated egl-15 or a lf clr-1 mutation.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the Hyperactive EGL-15 FGF signaling receptor development</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="7">
					<text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling, conferred by an activated egl-15 or a lf clr-1 mutation, may result in a Clr phenotype.</text>
					<arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF Hyperactive EGL-15 FGF receptor signaling</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="7">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF, conferred by an activated egl-15 or a mutation lf clr-1, may result in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="8">
					<text>resultedaresulted resultedrresultedoresultedlresultederesulted resultedoresultedfresulted resultedSresultedOresultedSresulted-resulted1resulted resultediresultednresulted resultedFresultedGresultedFresultedRresulted-resultedmresultederesulteddresultediresultedaresultedtresultederesulteddresulted resultedsresultediresultedgresultednresultedaresultedlresultediresultednresultedgresulted resulteddresulteduresultedrresultediresultednresultedgresulted resulteddresultederesultedvresultederesultedlresultedoresultedpresultedmresultederesultednresultedtresulted resultedTresultedhresultederesulted resultedsresultediresultedgresultednresultedaresultedlresultediresultednresultedgresulted resultedoresultedfresulted resultedFresultedGresultedFresulted resultedAresulted-resulted1resulted5resulted resultedFresultedGresultedFresulted resultedrresultederesultedcresultederesultedpresultedtresultedoresultedrresultedsresulted,resulted resultedcresultedoresultednresultedfresultederesultedrresultedrresultederesulteddresulted resultedbresultedyresulted resultedaresultednresulted resultedaresultedcresultedtresultediresultedvresultedaresultedtresultederesulteddresulted resultederesultedgresultedlresulted-resulted1resulted5resulted resultedoresultedrresulted resultedaresulted resultedlresultedfresulted resultedcresultedlresultedrresulted-resulted1resulted resultedmresulteduresultedtresultedaresultedtresultediresultedoresultednresulted,resulted resultedrresultederesultedsresulteduresultedlresultedtresultederesulteddresulted resultediresultednresulted resultedaresulted resultedCresultedlresultedrresulted resultedpresultedhresultederesultednresultedoresultedtresultedyresultedpresultederesulted.resulted</text>
					<arg n="0">a role of SOS-1 in FGFR-mediated signaling during development The signaling of FGF A-15 FGF receptors, conferred by an activated egl-15 or a lf clr-1 mutation, resulted in A1 (a Clr phenotype)</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="8">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF, conferred by an activated egl-15 or a mutation lf clr-1, has resulted in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling Hyperactive EGL-15 FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="9">
					<text>a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling, conferred by an activated egl-15 or a lf clr-1 mutation, has the ability to result in a Clr phenotype.</text>
					<arg n="0">a role of SOS-1 in FGFR-mediated signaling during the development of FGF EGL-15 Hyperactive receptor signaling</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="9">
					<text>a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive, conferred by an activated egl-15 or a lf clr-1 mutation, has the ability to result in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in signaling mediated by FGFR during the development of FGF receptor signaling EGL-15 Hyperactive</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="10">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, conferred by an activated egl-15 or a mutation lf clr-1, may result in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="10">
					<text>a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, conferred by an activated egl-15 or a lf clr-1 mutation, is able to result in a Clr phenotype.</text>
					<arg n="0">a role of SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="11">
					<text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling, conferred by an activated egl-15 or a lf clr-1 mutation, is observed to result in a Clr phenotype.</text>
					<arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="11">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, conferred by an activated egl-15 or a mutation lf clr-1, is observed to result in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="12">
					<text>a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF, conferred by an activated egl-15 or a clr-1 mutation, may have resulted in a Clr phenotype.</text>
					<arg n="0">a role of SOS-1 in the FGFR-mediated signaling during hyperactive development EGL-15 signaling receptor FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="12">
					<text>a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor, conferred by an activated egl-15 or a mutation lf clr-1, may have resulted in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in signaling mediated by FGFR during Hyperactive development EGL-15 FGF signaling receptor</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="13">
					<text>a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling, conferred by an activated egl-15 or a lf clr-1 mutation, may result in a Clr phenotype.</text>
					<arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of the FGF EGL-15 Hyperactive receptor signaling</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="13">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive, conferred by an activated egl-15 or a mutation lf clr-1, may result in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the FGF receptor signaling EGL-15 Hyperactive</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="14">
					<text>a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF, conferred by an activated egl-15 or a clr-1 mutation lf, resulted in a Clr phenotype.</text>
					<arg n="0">a role of SOS-1 in the FGFR-mediated signaling during the development of hyperactive signaling EGL-15 receptor FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="14">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor, conferred by an activated egl-15 or a mutation lf clr-1, resulted in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the Hyperactive signaling EGL-15 FGF receptor</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="15">
					<text>a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF, conferred by an activated egl-15 or a lf clr-1 mutation, will result in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in FGFR-mediated signaling during development Hyperactive signaling of FGF-15 receptors FGF</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="15">
					<text>a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors, conferred by an activated egl-15 or a mutation lf clr-1, will result in a Clr phenotype.</text>
					<arg n="0">a role for SOS-1 in the signaling mediated by FGFR during the development of the hyperactive signaling of FGF-15 receptors</arg>
					<arg n="1">a Clr phenotype</arg>
				</example>
				<example src="EGRAM" no="16">
					<text>The alternative exon 2 cutting (139 nt) and alternative transcriptional initiation is capable of result rise to mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="16">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation is capable of result rise to mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="17">
					<text>It is result that alternative exon 2 exhaustion (139 nt) and alternative transcriptional start results in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="17">
					<text>It is result that alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation results in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="18">
					<text>alternative exon 2 cutting (139 nt) and alternative transcriptional initiation can result in mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="18">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation can result in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="19">
					<text>alternative exon 2 exhaustion (139 nt) and alternative transcriptional start may have resulted in mRNA species with different 5 UTRs.</text>
					<arg n="0">alternative exon 2 exhaustion (139 nt) and alternative transcriptional start</arg>
					<arg n="1">mRNA species with different 5 UTRs</arg>
				</example>
				<example src="EGRAM" no="19">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have resulted in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="20">
					<text>The alternative exon 2 cutting (139 nt) and alternative transcriptional start resulted in the mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="20">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation have resulted in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="21">
					<text>The alternative exon 2 cutting (139 nt) and alternative transcriptional initiation has the ability to result in mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="21">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation has the ability to result in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="22">
					<text>The alternative exon 2 cutting (139 nt) and alternative transcriptional start may have resulted in mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="22">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation may have resulted in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="23">
					<text>The alternative exon 2 cutting (139 nt) and alternative transcriptional start resulted in the mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="23">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation resulted in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="24">
					<text>The alternative exon 2 cutting (139 nt) and alternative transcriptional start will result in the mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon 2 cutting (139 nt) and alternative transcriptional start</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="24">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation will result in mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation</arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="25">
					<text>alternative exon splicing 139 nt and alternative transcriptional initiation, as suggested in our study, are able to result in mRNA species with 5 distinct UTRs.</text>
					<arg n="0">alternative exon splicing 139 nt</arg>
					<arg n="1">mRNA species with 5 distinct UTRs</arg>
				</example>
				<example src="EGRAM" no="25">
					<text>The alternative exon coupling 139 nt and alternative transcriptional initiation, as result in our study, are capable of giving rise to mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon coupling 139 nt</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="26">
					<text>alternative exon splicing 139 nt and alternative transcriptional initiation, as suggested by our study, are result as a result in mRNA species with 5 distinct UTRs.</text>
					<arg n="0">alternative exon splicing 139 nt</arg>
					<arg n="1">mRNA species with 5 distinct UTRs</arg>
				</example>
				<example src="EGRAM" no="26">
					<text>alternative exon coupling 139 nt and alternative transcriptional initiation, as suggested by our study, are result as a result in mRNA species with 5 different UTRs.</text>
					<arg n="0">alternative exon coupling 139 nt</arg>
					<arg n="1">mRNA species with 5 different UTRs</arg>
				</example>
				<example src="EGRAM" no="34">
					<text>alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study,  will result in the mRNA species with different 5UTRs.</text>
					<arg n="0">alternative splicing of exon 2 (139 nt) and alternative transcriptional initiation, as suggested by our study, </arg>
					<arg n="1">mRNA species with different 5UTRs</arg>
				</example>
				<example src="EGRAM" no="35">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) is capable of result in high ratios of mature RNAm containing introns, which was not result for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="35">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) can result in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="36">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) is observed as resulting in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="36">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) are result as a result of high proportion of mature mRNAs containing introns, which has not been result for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="37">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) may result in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="37">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) can result in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="38">
					<text>both 5 and 3 splice mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) resulted in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="38">
					<text>both the mutations of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) has resulted in of high proportion of mature mRNA containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNA containing introns</arg>
				</example>
				<example src="EGRAM" no="39">
					<text>both 5 and 3 splice mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) has the ability to result in high ratios of mature RNAm containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both 5 and 3 splice mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="39">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) have the ability to result in of high proportion of mature mRNA containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNA containing introns</arg>
				</example>
				<example src="EGRAM" no="40">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) may have resulted in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="40">
					<text>both the mutations of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) may have resulted in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="41">
					<text>both 5 and 3 splice mutations (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) resulted in high proportion of mature RNA containing introns, which was not observed for other splicing mutations.</text>
					<arg n="0">both 5 and 3 splice mutations</arg>
					<arg n="1">high proportion of mature RNA containing introns</arg>
				</example>
				<example src="EGRAM" no="41">
					<text>both the mutations of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) resulted in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="42">
					<text>both 5 and 3 splice mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) will result in high ratios of mature RNAm containing introns, which has not been observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="42">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively) will result in of high proportion of mature mRNA containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNA containing introns</arg>
				</example>
				<example src="EGRAM" no="43">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively) in contrast, are able to result in high ratios of mature RNAm containing introns, which was not observed for other splicing mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="43">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively), in contrast, can result in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="44">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, results in high ratios of mature RNAm containing introns, which was not result for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="44">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively), is observed to result in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="45">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, may result in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="45">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively), in contrast, can result in of high proportion of mature mRNA containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNA containing introns</arg>
				</example>
				<example src="EGRAM" no="46">
					<text>both 5 and 3 splice mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, resulted in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="46">
					<text>both the mutations of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a respectively), in contrast, has resulted in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="47">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, has the ability to result in high ratios of mature RNAm containing introns, which was not observed for other splicing mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="47">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively), in contrast, have the ability to result in high-proportion mature mRNA containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">high-proportion mature mRNA containing introns</arg>
				</example>
				<example src="EGRAM" no="48">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, may have resulted in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="48">
					<text>both the mutations of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively), in contrast, may have resulted in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="49">
					<text>both 5 and 3 splice local mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, results in high ratios of mature RNAm containing introns, which was not result for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice local mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="49">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively), in contrast, results in of high proportion of mature mRNAs containing introns, which has not been result for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="50">
					<text>both 5 and 3 splice mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, resulted in high ratios of mature RNAm containing introns, which was not observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="50">
					<text>both the mutations of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a respectively), in contrast, resulted in of high proportion of mature mRNAs containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNAs containing introns</arg>
				</example>
				<example src="EGRAM" no="51">
					<text>both 5 and 3 splice mutations (1060 + 2t-&gt;c and 678-7g-&gt;a, respectively), in contrast, will result in high ratios of mature RNAm containing introns, which has not been observed for other splice mutations.</text>
					<arg n="0">both 5 and 3 splice mutations</arg>
					<arg n="1">high ratios of mature RNAm containing introns</arg>
				</example>
				<example src="EGRAM" no="51">
					<text>both the mutations at the site of 5 and 3 splices (1060 + 2t--&amp;gt;c and 678-7g--&amp;gt;a, respectively), in contrast, will result in of high proportion of mature mRNA containing introns, which has not been observed for other splicing mutations.</text>
					<arg n="0">both the mutations at the site of 5 and 3 splices</arg>
					<arg n="1">of high proportion of mature mRNA containing introns</arg>
				</example>
				<example src="EGRAM" no="52">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed that a new mutation in codon 210 could result in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="52">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 and was able to result in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="53">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 resulting in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="53">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman result by a family form of Creutzfeldt-Jakob's disease (JCD) revealed that a new mutation in codon 210 results in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="54">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="54">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed that a new mutation in codon 210 resulted in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="55">
					<text>Full sequencing of the open reading framework of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (CJD) revealed that a new mutation in codon 210 had the ability to result in replacing isoleukin with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacing isoleukin with valine</arg>
				</example>
				<example src="EGRAM" no="55">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed that a new mutation in codon 210 had the ability to result in replace isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replace isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="56">
					<text>The complete open reading sequence of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that has the ability to result in replacing isoleucine in valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacing isoleucine in valine</arg>
				</example>
				<example src="EGRAM" no="56">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that has the ability to result in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="57">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation in codon 210 that may result in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="57">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that is able to result in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="58">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation to codon 210 resulting in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation to codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="58">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that was observed to result in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="59">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation in codon 210 that could resulted in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="59">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that may have resulted in substitution of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">substitution of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="60">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="60">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation to codon 210 which resulted in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation to codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="61">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that may result in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="61">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation to codon 210 that may result in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation to codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="62">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that resulted in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="62">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation in codon 210 which resulted in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="63">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation in codon 210 results in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="63">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman results by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that results in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="64">
					<text>The full sequence of the open-reading table of the protein prion of a 68-year-old woman affected by a family form of Creutzfeldt-Jakob's disease (JCD) revealed a new mutation in codon 210 resulting in replacement of isoleucine with valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine with valine</arg>
				</example>
				<example src="EGRAM" no="64">
					<text>The full sequence of the open reading of the prion protein of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (JCD) revealed a new mutation in codon 210 that will result in replacement of isoleucine to valine.</text>
					<arg n="0">a new mutation in codon 210</arg>
					<arg n="1">replacement of isoleucine to valine</arg>
				</example>
				<example src="EGRAM" no="65">
					<text>The reduced EGL-15 signaling that can result in a phenotype of dirty body morphology (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
					<arg n="0">reduced EGL-15 signaling</arg>
					<arg n="1">a phenotype of dirty body morphology</arg>
				</example>
				<example src="EGRAM" no="65">
					<text>The Diminutive EGL-15 signal that can result in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">Diminutive EGL-15 signal</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="66">
					<text>reduction of EGL-15 signaling that resulted in dirty body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="66">
					<text>The decreases the EGL-15 signaling that has resulted in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">decreases the EGL-15 signaling</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="67">
					<text>The reduced signaling by EGL-15 that has the ability to result in a phenotype of dirty body morphology (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
					<arg n="0">reduced signaling by EGL-15</arg>
					<arg n="1">a phenotype of dirty body morphology</arg>
				</example>
				<example src="EGRAM" no="67">
					<text>The decreases the EGL-15 signaling that has the ability to result in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">decreases the EGL-15 signaling</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="68">
					<text>reduction of EGL-15 signaling that is able to result in a dirty body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">a dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="68">
					<text>The decreases the EGL-15 signaling that is capable of result rise to a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">decreases the EGL-15 signaling</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="69">
					<text>reduction of EGL-15 signaling that is observed results in dirty body morphology phenotype (Kokel et al., 1998) is result by a partial mutation of lf egl-15.</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="69">
					<text>The decreases the EGL-15 signaling that results in a phenotype of scrubbing body morphology(Kokel et al., 1998) is result by a partial mutation lf egl-15.</text>
					<arg n="0">decreases the EGL-15 signaling</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="70">
					<text>The reduction of the EGL-15 signaling that could have resulted in body's dirty morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the egl-15 lf.</text>
					<arg n="0">reduction of the EGL-15 signaling</arg>
					<arg n="1">body's dirty morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="70">
					<text>The declining EGL-15 that may have resulted in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">declining EGL-15</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="71">
					<text>reduction of EGL-15 signaling which may result in dirty body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="71">
					<text>The Diminutive EGL-15 signal that can result in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">Diminutive EGL-15 signal</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="72">
					<text>decreasing EGL-15 signal that resulted in scratched body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">decreasing EGL-15 signal</arg>
					<arg n="1">scratched body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="72">
					<text>The Diminutive EGL-15 signal that resulted in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">Diminutive EGL-15 signal</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="73">
					<text>reduction of EGL-15 signaling that results in dirty body morphology phenotype (Kokel et al., 1998) results conferred by a partial mutation of the lf egl-15.</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="73">
					<text>The decreases the EGL-15 signaling results in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">decreases the EGL-15 signaling</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="74">
					<text>reduction of EGL-15 signaling that will result in dirty body morphology phenotype (Kokel et al., 1998) is conferred by a partial mutation of the lf egl-15.</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="74">
					<text>The decreases the EGL-15 signaling resulting in a phenotype of scrubbing body morphology(Kokel et al., 1998) is conferred by a partial mutation lf egl-15.</text>
					<arg n="0">decreases the EGL-15 signaling</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="75">
					<text>reduction of EGL-15 signaling, conferred by a partial mutation of lf egl-15, may result in scratched body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">scratched body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="75">
					<text>GL-15 Decrease Flag, conferred by a partial mutation of lf egl-15, can result in a phenotype of scruwny body morphology(Kokel et al., 1998).</text>
					<arg n="0">GL-15 Decrease Flag</arg>
					<arg n="1">a phenotype of scruwny body morphology</arg>
				</example>
				<example src="EGRAM" no="76">
					<text>reduction of EGL-15 signaling, conferred by a partial mutation of lf egl-15, resulted in dirty body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="76">
					<text>The Diminutive EGL-15 signal, conferred by a partial mutation lf egl-15, has resulted in a phenotype of scrawny morphology(Kokel et al., 1998).</text>
					<arg n="0">Diminutive EGL-15 signal</arg>
					<arg n="1">a phenotype of scrawny morphology</arg>
				</example>
				<example src="EGRAM" no="77">
					<text>The reduced signaling by EGL-15, conferred by a partial mutation of lf egl-15, has the ability to result in pulled body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">reduced signaling by EGL-15</arg>
					<arg n="1">pulled body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="77">
					<text>The Diminutive EGL-15 signal, conferred by a partial mutation lf egl-15, has the ability to result in a phenotype of scrawny morphology(Kokel et al., 1998).</text>
					<arg n="0">Diminutive EGL-15 signal</arg>
					<arg n="1">a phenotype of scrawny morphology</arg>
				</example>
				<example src="EGRAM" no="78">
					<text>reduction of EGL-15 signaling, conferred by a partial mutation of lf egl-15, is able to result in scratched body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">scratched body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="78">
					<text>reduced EGL-15 signal, conferred by a partial mutation lf egl-15, is capable of result rise to a phenotype of scrawny morphology(Kokel et al., 1998).</text>
					<arg n="0">reduced EGL-15 signal</arg>
					<arg n="1">a phenotype of scrawny morphology</arg>
				</example>
				<example src="EGRAM" no="79">
					<text>decreasing EGL-15 sign, conferred by a partial mutation lf egl-15, is result as a result of scrutinic body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">decreasing EGL-15 sign</arg>
					<arg n="1">scrutinic body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="79">
					<text>Diminutive EGL-15 signal, conferred by a partial mutation lf egl-15, is observed to result in a phenotype of scruwny body morphology(Kokel et al., 1998).</text>
					<arg n="0">Diminutive EGL-15 signal</arg>
					<arg n="1">a phenotype of scruwny body morphology</arg>
				</example>
				<example src="EGRAM" no="80">
					<text>reduction of EGL-15 signaling, conferred by a partial mutation of lf egl-15, may have resulted in dirty body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="80">
					<text>Loading Signor of the EGL-15, conferred by a partial mutation of lf egl-15, may have resulted in a phenotype of scrawny morphology(Kokel et al., 1998).</text>
					<arg n="0">Loading Signor of the EGL-15</arg>
					<arg n="1">a phenotype of scrawny morphology</arg>
				</example>
				<example src="EGRAM" no="81">
					<text>reduction of EGL-15 signaling, conferred by a partial mutation of the lf egl-15, may result in scratched body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">scratched body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="81">
					<text>GL-15 Decrease Flag, conferred by a partial mutation of lf egl-15, can result in a phenotype of scruwny body morphology(Kokel et al., 1998).</text>
					<arg n="0">GL-15 Decrease Flag</arg>
					<arg n="1">a phenotype of scruwny body morphology</arg>
				</example>
				<example src="EGRAM" no="82">
					<text>reduction of EGL-15 signaling, conferred by a partial mutation of lf egl-15, resulted in dirty body morphology phenotype (Kokel et al., 1998).</text>
					<arg n="0">reduction of EGL-15 signaling</arg>
					<arg n="1">dirty body morphology phenotype</arg>
				</example>
				<example src="EGRAM" no="82">
					<text>Decrease Signor of the EGL-15, conferred by a partial mutation of lf egl-15, resulted in a phenotype of scrubbing body morphology(Kokel et al., 1998).</text>
					<arg n="0">Decrease Signor of the EGL-15</arg>
					<arg n="1">a phenotype of scrubbing body morphology</arg>
				</example>
				<example src="EGRAM" no="83">
					<text>exon 13 jump in s1031 animals can eventually result in a product of 543 bp.</text>
					<arg n="0">exon 13 jump in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="83">
					<text>Exon 13 jumping in s1031 animals can eventually result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="84">
					<text>exon 13 jump in s1031 animals can result in a product of 543 bp.</text>
					<arg n="0">exon 13 jump in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="84">
					<text>Exon 13 jumping in s1031 animals can result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="85">
					<text>Exon 13 jumping in s1031 animals eventually resulted in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="85">
					<text>exon 13 jumping in animals s1031 eventually resulted in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="86">
					<text>exon 13 jumping in animals s1031 eventually resulted in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="86">
					<text>Exon 13 jumping in s1031 animals has finally resulted in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="87">
					<text>exon 13 jumping in animals s1031 resulted in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="87">
					<text>Exon 13 jumping in s1031 animals has resulted in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="88">
					<text>exon 13 jumping in animals s1031 has the ability to result in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="88">
					<text>Exon 13 jumping in s1031 animals has the ability to eventually result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="89">
					<text>Exon 13 jumping in s1031 animals has the ability to result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="89">
					<text>exon 13 jumping in animals s1031 has the ability to result in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="90">
					<text>exon 13 jumping in animals s1031 is likely to resulting in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="90">
					<text>Exon 13 jumping in s1031 animals is likely to resulting in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="91">
					<text>Exon 13 jumping in s1031 animals is able to result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="91">
					<text>exon 13 jumping in animals s1031 is able to result in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="92">
					<text>Exon 13 jumping in s1031 animals is able to result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="92">
					<text>exon 13 jumping in animals s1031 is able to result in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="93">
					<text>exon 13 jumping in animals s1031 is finally result as a result in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="93">
					<text>Exon 13 jumping in s1031 animals is shown to ultimately result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="94">
					<text>exon 13 skipping in animals s1031 was shown to result in a 543 bp product.</text>
					<arg n="0">exon 13 skipping in animals s1031</arg>
					<arg n="1">a 543 bp product</arg>
				</example>
				<example src="EGRAM" no="94">
					<text>Exon 13 jumping in s1031 animals is shown to result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="95">
					<text>exon 13 jump in s1031 animals can ultimately resulted in a product of 543 bp.</text>
					<arg n="0">exon 13 jump in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="95">
					<text>Exon 13 jumping in s1031 animals may have finally resulted in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="96">
					<text>exon 13 jump in s1031 animals may have resulted in a product of 543 bp.</text>
					<arg n="0">exon 13 jump in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="96">
					<text>Exon 13 jumping in s1031 animals may have resulted in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="97">
					<text>exon 13 juar in s1031 animals resulted in a product of 543 bp.</text>
					<arg n="0">exon 13 juar in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="97">
					<text>Exon 13 jumping in s1031 animals resulted in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="98">
					<text>Exon 13 jumping in s1031 animals will eventually result in a product of 543 bp.</text>
					<arg n="0">Exon 13 jumping in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="98">
					<text>exon 13 jumping in animals s1031 will eventually result in a product of 543 bp.</text>
					<arg n="0">exon 13 jumping in animals s1031</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="99">
					<text>exon 13 jump in s1031 animals will result in a 543 bp product.</text>
					<arg n="0">exon 13 jump in s1031 animals</arg>
					<arg n="1">a 543 bp product</arg>
				</example>
				<example src="EGRAM" no="99">
					<text>exon 13 jump in s1031 animals will result in a product of 543 bp.</text>
					<arg n="0">exon 13 jump in s1031 animals</arg>
					<arg n="1">a product of 543 bp</arg>
				</example>
				<example src="EGRAM" no="100">
					<text>Expression of cDNA isoform II DNA in COS7 cells is eventually able to result in a marked increase in acetylhydrolase activity PAF.</text>
					<arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
					<arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
				</example>
				<example src="EGRAM" no="100">
					<text>CdNA II DNA expression of isoform II in COS7 cells is able to result in a marked increase in the acetylhydrase activity of PAF.</text>
					<arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
				</example>
				<example src="EGRAM" no="101">
					<text>expression of cADNA DNA isoform II in COS7 cells is able to result in a marked increase in acetylhydratelase PAF activity.</text>
					<arg n="0">expression of cADNA DNA isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in acetylhydratelase PAF activity</arg>
				</example>
				<example src="EGRAM" no="101">
					<text>CdNA II DNA expression of isoform II in COS7 cells is able to result in a marked increase in the acetylhydrase activity of PAF.</text>
					<arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
				</example>
				<example src="EGRAM" no="102">
					<text>It is result that expression of cDNA isoform II DNA in COS7 ultimately results in a marked increase in acetylhydrolase activity PAF.</text>
					<arg n="0">expression of cDNA isoform II DNA in COS7</arg>
					<arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
				</example>
				<example src="EGRAM" no="103">
					<text>It is result that expression of cDNA isoform II DNA in COS7 results in a marked increase in acetylhydrolase activity PAF.</text>
					<arg n="0">expression of cDNA isoform II DNA in COS7</arg>
					<arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
				</example>
				<example src="EGRAM" no="104">
					<text>Expression of cDNA isoform II DNA in COS7 cells may ultimately result in a marked increase in the activity of PAF acetylhydrolase.</text>
					<arg n="0">Expression of cDNA isoform II DNA in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
				</example>
				<example src="EGRAM" no="104">
					<text>Expression of the cD DNA of isoform II in COS7 cells may eventually result in a marked increase in the activity of acetylhydrolase PAF</text>
					<arg n="0">Expression of the cD DNA of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
				</example>
				<example src="EGRAM" no="105">
					<text>Expression of isoform II cDNA in COS7 cells may result in a marked increase in the activity of acetylhydralase of PAF.</text>
					<arg n="0">Expression of isoform II cDNA in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
				</example>
				<example src="EGRAM" no="105">
					<text>Expression of cDNA isoform II DNA in COS7 cells can result in a marked increase in the activity of PAF acetylhydrolase.</text>
					<arg n="0">Expression of cDNA isoform II DNA in COS7</arg>
					<arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
				</example>
				<example src="EGRAM" no="107">
					<text>expression of cDNA ISOform II DNA in COS7 cells eventually resulted in a marked increase in acetylhydrolase activity PAF.</text>
					<arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
					<arg n="1">a marked increase in acetylhydrolase activity PAF</arg>
				</example>
				<example src="EGRAM" no="107">
					<text>CdNA II DNA expression of isoform II in COS7 cells finally resulted in a marked increase in the acetylhydrase activity of PAF.</text>
					<arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
				</example>
				<example src="EGRAM" no="108">
					<text>Expression of cdNA II DNA of isoform II in COS7 cells resulted in a marked increase in the acetylhydrase activity of PAF .</text>
					<arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the acetylhydrase activity of PAF </arg>
				</example>
				<example src="EGRAM" no="108">
					<text>expression of cDNA ISOform II DNA in COS7 cells has resulted in a marked increase in the activity of acetylhydrolase PAF.</text>
					<arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
					<arg n="1">a marked increase in the activity of acetylhydrolase PAF</arg>
				</example>
				<example src="EGRAM" no="109">
					<text>expression of cDNA ISOform II DNA in COS7 cells has the ability to ultimately result in a marked increase in acetylhydrolase PAF activity.</text>
					<arg n="0">expression of cDNA ISOform II DNA in COS7</arg>
					<arg n="1">a marked increase in acetylhydrolase PAF activity</arg>
				</example>
				<example src="EGRAM" no="109">
					<text>CdNA II DNA expression of isoform II in COS7 cells has the ability to result in a marked increase in the acetylhydrase activity of PAF.</text>
					<arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
				</example>
				<example src="EGRAM" no="110">
					<text>DNA II expression of Isoform II DNA in COS7 has the ability to result in a marked increase in the activity of PAF acetylhydase.</text>
					<arg n="0">DNA II expression of Isoform II DNA in COS7</arg>
					<arg n="1">a marked increase in the activity of PAF acetylhydase</arg>
				</example>
				<example src="EGRAM" no="110">
					<text>CdNA II DNA expression of isoform II in COS7 cells has the ability to result in a marked increase in the acetylhydrase activity of PAF.</text>
					<arg n="0">CdNA II DNA expression of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the acetylhydrase activity of PAF</arg>
				</example>
				<example src="EGRAM" no="111">
					<text>Expression of cdNA II DNA of isoform II in COS7 cells may ultimately result in a marked increase in the activity of acetylhydralase of PAF.</text>
					<arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
				</example>
				<example src="EGRAM" no="111">
					<text>expression of the DNA-cDNA ISOform II in COS7 cells may eventually result in a marked increase in the activity of acetylhydroxylase PAF.</text>
					<arg n="0">expression of the DNA-cDNA ISOform II in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
				</example>
				<example src="EGRAM" no="112">
					<text>Expression of the cdNA II DNA from isoform II in COS7 may ultimately resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
					<arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
					<arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
				</example>
				<example src="EGRAM" no="112">
					<text>Expression of cdNA II DNA of isoform II in COS7 cells may ultimately resulted in a marked increase in the activity of acetylhydralase of PAF.</text>
					<arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
				</example>
				<example src="EGRAM" no="113">
					<text>expression of the DNA-cDNA ISOform II DNA in COS7 cells may have resulted in a marked increase in the activity of acetylhydroxylase PAF.</text>
					<arg n="0">expression of the DNA-cDNA ISOform II DNA in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydroxylase PAF</arg>
				</example>
				<example src="EGRAM" no="113">
					<text>Expression of the cdNA II DNA from isoform II in COS7 cells may have resulted in a marked increase in the activity of PAF acetylhydrolase.</text>
					<arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
					<arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
				</example>
				<example src="EGRAM" no="114">
					<text>Expression of cdNA II DNA of isoform II in COS7 cells may result in a marked increase in the activity of acetylhydralase of PAF .</text>
					<arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydralase of PAF </arg>
				</example>
				<example src="EGRAM" no="114">
					<text>Expression of the cdNA II DNA from isoform II in COS7 cells can result in a marked increase in the activity of PAF acetylhydrolase.</text>
					<arg n="0">Expression of the cdNA II DNA from isoform II in COS7</arg>
					<arg n="1">a marked increase in the activity of PAF acetylhydrolase</arg>
				</example>
				<example src="EGRAM" no="116">
					<text>Expression of cdNA II DNA of isoform II in COS7 cells will finally result in a marked increase in the activity of acetylhydralase of PAF.</text>
					<arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydralase of PAF</arg>
				</example>
				<example src="EGRAM" no="117">
					<text>Expression of cdNA II DNA of isoform II in COS7 cells will result in a marked increase in the activity of acetylhydralase of PAF .</text>
					<arg n="0">Expression of cdNA II DNA of isoform II in COS7 cells</arg>
					<arg n="1">a marked increase in the activity of acetylhydralase of PAF </arg>
				</example>
				<example src="EGRAM" no="118">
					<text>fluctuation in signaling depending on ras can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in signaling depending on ras</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="118">
					<text>glow in signaling depending on the ras can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">glow in signaling depending on the ras</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="119">
					<text>The grid-dependent fluctuation in signaling has resulted in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">grid-dependent fluctuation in signaling</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="119">
					<text>fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="120">
					<text>fluctuation in signaling depending on ras has the ability to result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in signaling depending on ras</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="120">
					<text>The glow in signalling depending on the ras has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">glow in signalling depending on the ras</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="121">
					<text>fluctuation in ras-dependent signaling is likely to resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="121">
					<text>fluctuation in ras-dependent signaling is likely to resulting in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="122">
					<text>The glow in signalling depending on the ras is capable of result rise to a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">glow in signalling depending on the ras</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="122">
					<text>fluctuation in signaling depending on ras is capable of result rise to a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in signaling depending on ras</arg>
					<arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="123">
					<text>It is result that growth in ras-dependent signaling results in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">growth in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="124">
					<text>fluctuation in ras-dependent signaling may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="124">
					<text>fluctuation in signaling depending on the ras may have resulted in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in signaling depending on the ras</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="125">
					<text>glow in signaling depending on the ras can result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">glow in signaling depending on the ras</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="125">
					<text>fluctuation in ras-dependent signaling may result in a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvul induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="126">
					<text>fluctuation in ras-dependent signaling resulted in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="126">
					<text>reduction of signaling as a function of ras resulted in a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">reduction of signaling as a function of ras</arg>
					<arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="128">
					<text> fluctuation in signaling depending on the ras will result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0"> fluctuation in signaling depending on the ras</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="128">
					<text>fluctuation in signaling depending on the ras will result in a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in signaling depending on the ras</arg>
					<arg n="1">a dramatic change in vulvulus induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="129">
					<text>fluctuation in ras-dependent signaling, as predicted, can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="129">
					<text>fluctuation in ras-dependent signaling, as we have predicted, may result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="130">
					<text>The glow-dependent signaling fluctuation, as predicted, has resulted in the a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">glow-dependent signaling fluctuation</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="130">
					<text>fluctuation in ras-dependent signaling, as we have predicted, resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="131">
					<text>The grid-dependent fluctuation in signaling, as predicted, has the ability to result in a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">grid-dependent fluctuation in signaling</arg>
					<arg n="1">a dramatic change in volval induction under the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="131">
					<text>fluctuation in ras-dependent signaling, as we have predicted, has the ability to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="132">
					<text>fluctuation in ras-dependent signaling, as we have predicted, is likely to resulting in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="132">
					<text>reduction of signaling as a function of ras, as we have predicted, may resulting in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">reduction of signaling as a function of ras</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="133">
					<text>float in ras-dependent signaling, as we have result, is able to give rise to a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">float in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in volval induction under the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="133">
					<text>fluctuation in ras-dependent signaling, as we have predicted, is able to result in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="134">
					<text>fluctuation in ras-dependent signaling, as result, results in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="134">
					<text>fluctuation in ras-dependent signaling, as we have result, results in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="135">
					<text>fluctuation in ras-dependent signaling, as predicted, may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="135">
					<text>fluctuation in ras-dependent signaling, as we have predicted, may have resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="136">
					<text>fluctuation in ras-dependent signaling, as predicted, can result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="136">
					<text>fluctuation in ras-dependent signaling, as we have predicted, may result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="137">
					<text>fluctuation in ras-dependent signaling, as predicted, resulted in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="137">
					<text>fluctuation in ras-dependent signaling, as we have predicted, resulted in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="138">
					<text>fluctuation in ras-dependent signaling, as results, results in a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="138">
					<text>fluctuation in ras-dependent signaling, as we have results, results in a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition where there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="139">
					<text>fluctuation in ras-dependent signaling, as predicted, will result in a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level LET-23/SEM-5/SOS-1 activity</arg>
				</example>
				<example src="EGRAM" no="139">
					<text>fluctuation in ras-dependent signaling, as we have predicted, will result in a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1.</text>
					<arg n="0">fluctuation in ras-dependent signaling</arg>
					<arg n="1">a dramatic change in vulvar induction in the condition that there is a low-level activity of LET-23/SEM-5/SOS-1</arg>
				</example>
				<example src="EGRAM" no="140">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes some alternative subdomains result able to give the complete result a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="140">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains and result able to give the full result super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="141">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains and may result rise to super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="141">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes some alternative subdomains result able to give rise to a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="142">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains that results in superrepetition.</text>
					<arg n="0">alternative mixed subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="143">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternate subdomains and is observed to result in superrepetition.</text>
					<arg n="0">multiple alternate subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="143">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes multiple alternative subdomains and is observed to result in superrepetition.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="144">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains resulted in the complete super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="144">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes some alternative subdomains having resulted in the complete a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="145">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes some alternative subdomains after having resulted a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="145">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains after having resulted super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="146">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains with ability to entirely result in superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">superrepetitor</arg>
				</example>
				<example src="EGRAM" no="146">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes some alternative subdomains with the ability to result entirely in a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="147">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes some alternative subdomains with ability to result in super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="147">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes some alternative subdomains with the ability to result in a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="148">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes mixed alternative subdomains that can result in a superrepetitor.</text>
					<arg n="0">mixed alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="148">
					<text>The human mucin gene MUC5B, the 10.7 kb central exon, codes multiple alternate subdomains that are able to completely result in superrepetition.</text>
					<arg n="0">multiple alternate subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="149">
					<text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes some alternative subdomains that are capable of result rise to a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="149">
					<text>The human mucin gene MUC5B, the great 10.7kb of central exon codes some alternative subdomains that result able to give rise to super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="150">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains that are result as entirely super-repetitor.</text>
					<arg n="0">alternative mixed subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="150">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes mixed alternative subdomains that are observed to result entirely in a superrepetitor.</text>
					<arg n="0">mixed alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="151">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes multiple alternative subdomains that are result as a result of a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="151">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes multiple alternative subdomains that are result as the result of super-repetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="152">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes mixed alternative subdomains which can result entirely in a superrepetitor.</text>
					<arg n="0">mixed alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="152">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes alternative mixed subdomains that can result entirely in super-repetitor.</text>
					<arg n="0">alternative mixed subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="153">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes multiple alternative subdomains which can result in superrepetition.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="153">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes multiple alternative subdomains which can result in a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="154">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes mixed alternative subdomains that result entirely in a superrepetitor.</text>
					<arg n="0">mixed alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="155">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, codes alternative mixed subdomains that resulted in superrepetition.</text>
					<arg n="0">alternative mixed subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="155">
					<text>The human mucin gene MUC5B, a central exon of 10.7 kb, encodes mixed alternative subdomains which resulted in a superrepetitor.</text>
					<arg n="0">mixed alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="156">
					<text>The human mucin gene MUC5B, the great 10.7kb of central exon codes multiple alternative subdomains that resulted in superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">superrepetitor</arg>
				</example>
				<example src="EGRAM" no="156">
					<text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes multiple alternative subdomains that have resulted in a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="157">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternate subdomains that resulted in superrepetition.</text>
					<arg n="0">multiple alternate subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="157">
					<text>The human mucin gene MUC5B, the 10.7kb large central exon encodes some alternative subdomains that have resulted in a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="158">
					<text>The human mucin gene MUC5B, the 10.7kb central exon, codes some alternative subdomains that has the ability to completely result in super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="158">
					<text>The human mucin gene MUC5B, the 10.7kb large central exon encodes some alternative subdomains that have the ability to result completely in a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="159">
					<text>The human mucin gene MUC5B, the central exon of 10.7kb, codes some alternative subdomains that has the ability to result in super-repetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="159">
					<text>The human mucin gene MUC5B, the 10.7kb large central exon encodes some alternative subdomains that have the ability to result in a superrepetitor.</text>
					<arg n="0">some alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="160">
					<text>The human mucin gene MUC5B, the great 10.7kb of central exon codes multiple alternative subdomains which may have resulted entirely in super-repetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="160">
					<text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes multiple alternative subdomains that may have resulted entirely in a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="161">
					<text>The human mucin gene MUC5B, the great 10.7kb of central exon codes multiple alternative subdomains that may have resulted in super-repetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="161">
					<text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes multiple alternative subdomains that may have resulted in a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="162">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes multiple alternative subdomains resulting in superrepetition.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="162">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, encodes multiple alternative subdomains resulting in a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="163">
					<text>The human mucin gene MUC5B, the central exon of 10.7kb, codes multiple alternate subdomains that resulted in superrepetition.</text>
					<arg n="0">multiple alternate subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="163">
					<text>The human mucin gene MUC5B, 10.7 kb of large central exon encodes multiple alternative subdomains which resulted in a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="164">
					<text>The human mucin gene MUC5B, the large 10.7kb of central exon codes alternative mixed subdomains that will result in super-repetitor.</text>
					<arg n="0">alternative mixed subdomains</arg>
					<arg n="1">super-repetitor</arg>
				</example>
				<example src="EGRAM" no="164">
					<text>The human mucin gene MUC5B, the large 10.7kb of central exon encodes mixed alternative subdomains that will result in a superrepetitor.</text>
					<arg n="0">mixed alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="165">
					<text>The human mucin gene MUC5B, the 10.7kb large central exon encodes multiple alternative subdomains resulting in a superrepetitor.</text>
					<arg n="0">multiple alternative subdomains</arg>
					<arg n="1">a superrepetitor</arg>
				</example>
				<example src="EGRAM" no="165">
					<text>The human mucin gene MUC5B, the central exon of 10.7 kb, codes multiple alternate subdomains that will result in superrepetition.</text>
					<arg n="0">multiple alternate subdomains</arg>
					<arg n="1">superrepetition</arg>
				</example>
				<example src="EGRAM" no="166">
					<text>Induction of a mutation in the lacI gene may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="166">
					<text>Induction of a mutation in the lacI gene can result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="167">
					<text>Induction of a mutation in the lacI gene may have resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="167">
					<text>Induction of a mutation in the lacI gene may have resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="168">
					<text>Induction of a mutation in the lacI gene resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="168">
					<text>Induction of a mutation in the lacI gene has resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="169">
					<text>Induction of a mutation in the lacI gene has the ability to result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="169">
					<text>Induction of a mutation in the lacI gene has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="170">
					<text>Induction of a mutation in the lacI gene result capable of result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="170">
					<text>Induction of a mutation in the lacI gene is able to result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="171">
					<text>The induction of a mutation in the lacI gene is observed to result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="172">
					<text>Induction of a mutation in the lacI gene may have resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="172">
					<text>Induction of a mutation in the lacI gene may have resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="173">
					<text>Induction of a mutation in the lacI gene may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="173">
					<text>Induction of a mutation in the lacI gene may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="174">
					<text>Induction of a mutation in the lacI gene resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="174">
					<text>Induction of a mutation in the lacI gene resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="176">
					<text>Induction of a mutation in the lacI gene will result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="176">
					<text>Induction of a mutation in the lacI gene will result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="177">
					<text>Induction of a mutation in the lacI gene, as revealed by our study, may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="177">
					<text>Induction of a mutation in the lacI gene, as our study revealed, may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="178">
					<text>Induction of a mutation in the lacI gene, as revealed by our study, could have resulted in losing the transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">losing the transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="178">
					<text>Induction of a mutation in the lacI gene, as our study revealed, could resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="179">
					<text>Induction of a mutation in the lacI gene, as our study revealed, resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="179">
					<text>The induction of a mutation in the lacI gene, as revealed by our study, has resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="180">
					<text>The induction of a mutation in the lacI gene, as revealed by our study, has the ability to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="180">
					<text>Induction of a mutation in the lacI gene, as our study revealed, has the ability to result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="181">
					<text>Induction of a mutation in the lacI gene, as our study revealed, is able to result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="181">
					<text>Inducing a mutation in the lacI gene, as our study has shown, is capable of result the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
				</example>
				<example src="EGRAM" no="182">
					<text>The induction of a mutation in the lacI gene, as our study result, results in loss due to transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss due to transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="182">
					<text>The induction of a mutation in the lacI gene, as revealed in our study, is seen to result in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="183">
					<text>Induction of a mutation in the lacI gene, as our study revealed, may have resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="183">
					<text>Induction of a mutation in the lacI gene, as revealed by our study, may have resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
				</example>
				<example src="EGRAM" no="184">
					<text>Induction of a mutation in the lacI gene, as revealed by our study, may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="184">
					<text>Induction of a mutation in the lacI gene, as our study revealed, may result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="185">
					<text>The induction of a mutation in the lacI gene, as revealed by our study, resulted in the loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">the loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="185">
					<text>Induction of a mutation in the lacI gene, as our study revealed, resulted in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="186">
					<text>Induction of a mutation in the lacI gene, as our study results, results in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="186">
					<text>Induction of a mutation in the lacI gene, as our study results, results in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="187">
					<text>Induction of a mutation in the lacI gene, as our study has shown, will result in loss of transcriptional repression of the lacZ gene in mutated cells.</text>
					<arg n="0">loss of transcriptional repression of the lacZ gene</arg>
				</example>
				<example src="EGRAM" no="187">
					<text>Inducing a mutation in the lacI gene, as our study has shown, will result in the loss of the transcriptional repression of the lacZ gene in mutated cells.</text>
				</example>
				<example src="EGRAM" no="188">
					<text>Mutations that may result in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="188">
					<text>Mutations that can result in symultaneous derepression of both genes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="189">
					<text>The mutations that were observed result in an symultaneous derepression of both genes can result the binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="189">
					<text>The mutations that were observed result in simultaneous derepression of both genes may result the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="190">
					<text>Mutations that resulted in simultaneous derepression of both genes may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="190">
					<text>Mutations that have resulted in  simultaneous derepression of both genes can prevent repressor binding to any site or alter the binding phase of the binding sites.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="191">
					<text>Mutations that have the ability to result in symultaneous derepression of both genes can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="191">
					<text>Mutations that have the ability to result in simultaneous derepression of both genes may prevent the binding of repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="192">
					<text>Mutations that resulting in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="192">
					<text>Mutations that resulting in symultaneous derepression of both genes can avoid binding of repressors to the site or change the site binding phase.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="193">
					<text>Mutations that can result in symultaneous derepression of both genes can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="193">
					<text>Mutations that are able to result in simultaneous derepression of both genes may prevent the binding of repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="194">
					<text>Mutations that result in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="194">
					<text>Mutations that result in symultaneous derepression of both genes can avoid binding of repressors to the site or change the site binding phase.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="195">
					<text>Mutations that may result in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="195">
					<text>Mutations that can result in symultaneous derepression of both genes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="196">
					<text>Mutations that resulted in simultaneous derepression of both genes may prevent the binding of repressors to any site or change the binding phase of the binding sites.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="196">
					<text>Mutations that have resulted in  simultaneous derepression of both genes can prevent repressor binding to any site or alter the binding phase of the binding sites.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="197">
					<text>Mutations that have the ability to result in symultaneous derepression of both genes can prevent the binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="197">
					<text>Mutations that have the ability to result in simultaneous derepression of both genes may prevent the binding of repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="198">
					<text>Mutations that may resulted in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="198">
					<text>Mutations that can resulted in symultaneous derepression of both genes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="199">
					<text>Mutations that may result in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="199">
					<text>Mutations that can result in symultaneous derepression of both genes can avoid binding of repressors to the site or change the binding phase of the binding site.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="200">
					<text>Mutations that result in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="200">
					<text>Mutations that result in symultaneous derepression of both genes can avoid binding of repressors to the site or change the site binding phase.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="201">
					<text>Mutations that resulted in symultaneous derepression of both genes can prevent repressor binding to the site or change the site binding phase.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="201">
					<text>Mutations that resulted in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="202">
					<text>Mutations that result in simultaneous derepression of both genes may prevent the binding of the repressors to the site or change the binding site phase.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="202">
					<text>Mutations that result in symultaneous derepression of both genes can avoid binding of repressors to the site or change the site binding phase.</text>
					<arg n="0">symultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="203">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites can result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="203">
					<text>Mutations that prevent repressor bonding to the site or alter the binding phase of the sites are able to result in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="204">
					<text>Mutations that result the binding of repressors to the site or alter the phase of the binding sites result in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="204">
					<text>Mutations that result repressor binding to any site or alter the binding phase of the binding sites are observed as a result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="205">
					<text>Mutations that prevent the binding of repressors to any site or alter the binding phase of the binding sites may result in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="205">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites can result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="206">
					<text>Mutations that prevent the binding of repressors to any site or alter the binding phase of the binding sites resulted in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="206">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites have resulted in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="207">
					<text>Mutations that prevent the binding of repressors to any site or alter the binding phase of the binding sites have the ability to result in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="207">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites have the ability to result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="208">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites may have resulted in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="208">
					<text>Mutations that prevent the binding of repressors to any site or alter the binding phase of the binding sites may have resulted in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="209">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites can result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="209">
					<text>Mutations that prevent the binding of repressors to any site or alter the binding phase of the binding sites may result in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="210">
					<text>Mutations that result repressor binding to any site or alter the binding phase of the binding sites result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="210">
					<text>Mutations that result the binding of repressors to any site or alter the binding phase of the binding sites result in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="211">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites resulted in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="211">
					<text>Mutations that prevent the binding of the repressor to any site or alter the binding phase of the binding sites resulted in simultaneous derepression of both genes.</text>
					<arg n="0">simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="212">
					<text>Mutations that prevent repressors from binding to the site or alter the binding phase of the binding sites will result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="212">
					<text>Mutations that prevent repressor binding to any site or alter the binding phase of the binding sites will result in  simultaneous derepression of both genes.</text>
					<arg n="0"> simultaneous derepression of both genes</arg>
				</example>
				<example src="EGRAM" no="213">
					<text>a variant can probably result the result of the normal docking donor site of intron 12 could not result used.</text>
					<arg n="0">the normal docking donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="213">
					<text>a variant may probably result the result of the normal site of the intron 12 fitting donor could not result used.</text>
					<arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="214">
					<text>a variant can result the result of the normal docking donor site of intron 12 could not result used.</text>
					<arg n="0">the normal docking donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="214">
					<text>a variant may result the result of the normal site of the intron 12 fitting donor could not result used.</text>
					<arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="215">
					<text>a variant result probably the result of failure to use the normal site of the intron 12 splice donor.</text>
					<arg n="0">failure to use the normal site of the intron 12 splice donor</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="215">
					<text>It has been result that a variant is probably the result of the normal splice donor site of intron 12 could not be used.</text>
					<arg n="0">the normal splice donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="216">
					<text>a variant result the result of the normal splice donor site of intron 12 could not be used.</text>
					<arg n="0">the normal splice donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="216">
					<text>It has been result that a variant is the result of the place of normal splice donor of intron 12 could not be used.</text>
					<arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="217">
					<text>a variant resulted probably the result of the normal splice donor site of intron 12 could not be used.</text>
					<arg n="0">the normal splice donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="217">
					<text>a variant has probably resulted the result of the place of normal splice donor of intron 12 could not be used.</text>
					<arg n="0">the place of normal splice donor of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="218">
					<text>a variant resulted the result of the donor place of normal helix of intron 12 could not be used.</text>
					<arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="218">
					<text>a variant resulted the result of the donor site of the normal helix of intron 12 could not be used.</text>
					<arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="219">
					<text>a variant probably result the result of the normal site of the intron 12 splice donor could not be used.</text>
					<arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="219">
					<text>a variant has probably result the result of the normal splice donor site of intron 12 could not be used.</text>
					<arg n="0">the normal splice donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="220">
					<text>a variant was result to be the result of the normal site of the intron 12 fitting donor could not be used.</text>
					<arg n="0">the normal site of the intron 12 fitting donor could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="220">
					<text>a variant has been result to be the result of the normal docking donor site of intron 12 could not be used.</text>
					<arg n="0">the normal docking donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="221">
					<text>a variant has the ability to probably result from failure to use the normal donor site of the intron 12 ear.</text>
					<arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="221">
					<text>a variant has the ability to probably result from not to use the normal donor site of the intron 12 ear.</text>
					<arg n="0">not to use the normal donor site of the intron 12 ear</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="222">
					<text>a variant has the ability to result from missing to use the normal donor site of the ear 12 intron.</text>
					<arg n="0">missing to use the normal donor site of the ear 12 intron</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="222">
					<text>a variant has the ability to result from failure to use the normal donor site of the intron 12 ear.</text>
					<arg n="0">failure to use the normal donor site of the intron 12 ear</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="223">
					<text>a variant resulted probably the result of the normal donor site of intron 12 donation could not be used.</text>
					<arg n="0">the normal donor site of intron 12 donation could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="223">
					<text>a variant resulted probably the result of the normal docking donor site of intron 12 could not be used.</text>
					<arg n="0">the normal docking donor site of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="224">
					<text>a variant resulted the result of the normal splice donor site of the 12th intron could not be used.</text>
					<arg n="0">the normal splice donor site of the 12th intron could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="224">
					<text>a variant resulted the result of the normal site of the intron 12 splice donor could not be used.</text>
					<arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="225">
					<text>a variant was probably able to result from the normal site of the intron 12 splice donor could not be used.</text>
					<arg n="0">the normal site of the intron 12 splice donor could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="225">
					<text>a variant was probably able to result from not to use the normal donor site of the intron 12 splice.</text>
					<arg n="0">not to use the normal donor site of the intron 12 splice</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="226">
					<text>a variant was able to result from failure to use the normal donor site of splice of intron 12.</text>
					<arg n="0">failure to use the normal donor site of splice of intron 12</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="226">
					<text>a variant was able to result from not to use the normal donor site of the coupling of intron 12.</text>
					<arg n="0">not to use the normal donor site of the coupling of intron 12</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="227">
					<text>a variant was probably result as a result of the donor place of normal helix of intron 12 could not be used.</text>
					<arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="227">
					<text>a variant was probably result as a result of the donor site of the normal helix of intron 12 could not be used.</text>
					<arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="228">
					<text>a variant was result as a result of the donor place of normal helix of intron 12 could not be used.</text>
					<arg n="0">the donor place of normal helix of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="228">
					<text>a variant was result as a result of the donor site of the normal helix of intron 12 could not be used.</text>
					<arg n="0">the donor site of the normal helix of intron 12 could not be used</arg>
					<arg n="1">a variant</arg>
				</example>
				<example src="EGRAM" no="229">
					<text>Sequence analysis of the IDHbeta gene indicates that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) may resulted from alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="229">
					<text>Sequence analysis of the HDIbeta gene indicates that difference in C-terminal 28 amino acids between the beta(1) and beta(2) proteins may resulted from A0 (alternative of a single transcription cut) (difference in C-terminal 28 amino acids between the beta(1) and beta(2) proteins may resulted from alternative of a single transcription cut.</text>
					<arg n="0">alternative of a single transcription cut</arg>
					<arg n="1">difference in C-terminal 28 amino acids between the beta(1) and beta(2) proteins may result from A0 (alternative of a single transcription cut)</arg>
				</example>
				<example src="EGRAM" no="230">
					<text>The sequence analysis of the HDIbeta gene result that difference in the 28 C-terminal amino acids between beta(1) and beta(2) has been the result of alternative spacer of a single transcription.</text>
					<arg n="0">alternative spacer of a single transcription</arg>
					<arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="230">
					<text>Sequence analysis of the IDHbeta gene result that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) has been shown to be the result of alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="231">
					<text>Sequence analysis of the HDIbeta gene resulted that difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) is the result of alternative of a single transcription cut.</text>
					<arg n="0">alternative of a single transcription cut</arg>
					<arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="231">
					<text>Sequence analysis of the IDHbeta gene indicates that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) has resulted from alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="232">
					<text>The sequence analysis of the HDIbeta gene indicates that difference in the 28 C-terminal amino acids between beta(1) and beta(2) has the ability to result from alternative spacer of a single transcription.</text>
					<arg n="0">alternative spacer of a single transcription</arg>
					<arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="232">
					<text>Sequence analysis of the IDHbeta gene indicates that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) has the capability to result from alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="233">
					<text>Sequence analysis of the IDHbeta gene indicates that the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins is able to result from alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between the beta(1) and beta(2) proteins</arg>
				</example>
				<example src="EGRAM" no="233">
					<text>The sequence analysis of the HDIbeta gene indicates that difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription) (difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from alternative spacer of a single transcription.</text>
					<arg n="0">alternative spacer of a single transcription</arg>
					<arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2) proteins is able to result from A0 (alternative spacer of a single transcription)</arg>
				</example>
				<example src="EGRAM" no="234">
					<text>The sequence analysis of the HDIbeta gene result that difference in the 28 C-terminal amino acids between beta(1) and beta(2) is the result of alternative spacer of a single transcription.</text>
					<arg n="0">alternative spacer of a single transcription</arg>
					<arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="234">
					<text>Sequence analysis of the IDHbeta gene result that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) is the result of alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="235">
					<text>Sequence analysis of the IDHbeta gene resulted that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) may have been the result of alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="235">
					<text>Sequence analysis of the HDIbeta gene resulted that difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut) (difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of alternative of a single transcription cut.</text>
					<arg n="0">alternative of a single transcription cut</arg>
					<arg n="1">difference in C-terminal 28 amino acids between proteins beta(1) and beta(2) may have been the result of A0 (alternative of a single transcription cut)</arg>
				</example>
				<example src="EGRAM" no="236">
					<text>The sequence analysis of the HDIbeta gene resulted that difference in the 28 C-terminal amino acids between beta(1) and beta(2) is the result of alternative spacer of a single transcription.</text>
					<arg n="0">alternative spacer of a single transcription</arg>
					<arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="236">
					<text>Sequence analysis of the IDHbeta gene resulted that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) is the result of alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="237">
					<text>The sequence analysis of the HDIbeta gene result that difference in the 28 C-terminal amino acids between beta(1) and beta(2) will be the result of alternative deflection of a single transcription.</text>
					<arg n="0">alternative deflection of a single transcription</arg>
					<arg n="1">difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="237">
					<text>Sequence analysis of the IDHbeta gene result that the difference in the 28 C-terminal amino acids between beta(1) and beta(2) will be the result of alternative splicing of a single transcription.</text>
					<arg n="0">alternative splicing of a single transcription</arg>
					<arg n="1">the difference in the 28 C-terminal amino acids between beta(1) and beta(2)</arg>
				</example>
				<example src="EGRAM" no="238">
					<text>The alteration can result thermal instability and affect the liquid charge of the variant subunit and ultimately results in the an electrophoretic subunit of fast-type LDH-B subunits.</text>
					<arg n="0">liquid charge of the variant subunit</arg>
					<arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
				</example>
				<example src="EGRAM" no="238">
					<text>The change can cause heat instability and affect the net charge of the variant subunit by finally being able to result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="239">
					<text>The alteration can cause thermal instability and affect liquid load of the variable subunit because it is able to result in fast-type electrophoretic subunit LDH-B.</text>
					<arg n="0">liquid load of the variable subunit</arg>
					<arg n="1">fast-type electrophoretic subunit LDH-B</arg>
				</example>
				<example src="EGRAM" no="239">
					<text>The change can cause heat instability and affect the net charge of the varying subunit by being able to result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the varying subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="240">
					<text>The alteration can result thermal instability and affect the net charge of the variant subunit which ultimately results in a fast-type electrophoretic subunit LDH-B of variant.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
				</example>
				<example src="EGRAM" no="240">
					<text>The alteration can cause thermal instability and affect the net load of the variant subunit being observed to finally result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">the net load of the variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="241">
					<text>The alteration can cause thermal instability and affect the net load of the variant subunit being observed to result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">the net load of the variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="241">
					<text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic subunit variant of the fast type LDH-B.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">an electrophoretic subunit variant of the fast type LDH-B</arg>
				</example>
				<example src="EGRAM" no="242">
					<text>The change can cause thermal instability and affect the net load of the variant subunit and is shown to finally result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">the net load of the variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="242">
					<text>The change can cause thermal instability and affect the net charge of the variant subunit and is shown to ultimately result in an electrophoretic subunit fast type LDH-B.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">an electrophoretic subunit fast type LDH-B</arg>
				</example>
				<example src="EGRAM" no="243">
					<text>The alteration may cause thermal instability and affect the net load of the variant subunit being demonstrated to result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">the net load of the variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="243">
					<text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is shown to result in an electrophoretic subunit fast type LDH-B.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">an electrophoretic subunit fast type LDH-B</arg>
				</example>
				<example src="EGRAM" no="244">
					<text>Alteration can resulted thermal instability and affect the liquid charge of varying subunits and ultimately results in the an electrophoretic subunit of fast-type LDH-B subunits.</text>
					<arg n="0">liquid charge of varying subunits</arg>
					<arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
				</example>
				<example src="EGRAM" no="244">
					<text>The change can cause heat instability and affect the net charge of the varying subunit after it has resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the varying subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="245">
					<text>The alteration can cause thermal instability and affect liquid load of the variant subunit after having resulted in fast-type electrophoretic subunit LDH-B.</text>
					<arg n="0">liquid load of the variant subunit</arg>
					<arg n="1">fast-type electrophoretic subunit LDH-B</arg>
				</example>
				<example src="EGRAM" no="245">
					<text>The change can cause heat instability and affect the net charge of the variant subunit after it has resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="246">
					<text>The alteration may cause thermal instability and affect liquid load of variant subunit which finally resulted in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="246">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which has finally resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="247">
					<text>The alteration may cause thermal instability and affect liquid load of variant subunit which resulted in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="247">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which has resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="248">
					<text>The alteration may cause thermal instability and affect liquid load of the variant subunit, which may eventually result in fast-type electrophoretic subunit LDH-B.</text>
					<arg n="0">liquid load of the variant subunit</arg>
					<arg n="1">fast-type electrophoretic subunit LDH-B</arg>
				</example>
				<example src="EGRAM" no="248">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which will eventually result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="249">
					<text>The change may result thermal instability and affect liquid load of variant subunit which results in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="249">
					<text>Change can cause heat instability and affect the net charge of the varying subunit resulting in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the varying subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="250">
					<text>The alteration can cause thermal instability and affect liquid charge of varying subunits, which can result in an electrophoretic subunit of fast-type LDH-B subunits.</text>
					<arg n="0">liquid charge of varying subunits</arg>
					<arg n="1">an electrophoretic subunit of fast-type LDH-B subunits</arg>
				</example>
				<example src="EGRAM" no="250">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which can eventually result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="251">
					<text>The alteration may cause thermal instability and affect liquid load of variant subunit which may result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="251">
					<text>The change can cause heat instability and affect the net charge of the varying subunit which can result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the varying subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="252">
					<text>The alteration can cause thermal instability and affect liquid load of the variant subunit, which ended up resulted in fast-type electrophoretic subunit LDH-B.</text>
					<arg n="0">liquid load of the variant subunit</arg>
					<arg n="1">fast-type electrophoretic subunit LDH-B</arg>
				</example>
				<example src="EGRAM" no="252">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which eventually resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="253">
					<text>The alteration can results thermal instability and affect liquid charge of varying subunits, which ultimately results in an electrophoretic subunit of fast LDH-B subunits.</text>
					<arg n="0">liquid charge of varying subunits</arg>
					<arg n="1">an electrophoretic subunit of fast LDH-B subunits</arg>
				</example>
				<example src="EGRAM" no="253">
					<text>The change can results heat instability and affect the net charge of the variant subunit which eventually results in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="254">
					<text>The alteration can cause thermal instability and affect the net load of the variant subunit which has proven to result finally in a variant electrophoretic subunit LDH-B .</text>
					<arg n="0">the net load of the variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B </arg>
				</example>
				<example src="EGRAM" no="254">
					<text>The alteration can result thermal instability and affect the net charge of the variant subunit which has finally been shown to be an electrophoretic subunit LDH-B.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">an electrophoretic subunit LDH-B</arg>
				</example>
				<example src="EGRAM" no="255">
					<text>The alteration may cause thermal instability and affect liquid load of variant subunit which has been demonstrated to result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="255">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which has been shown to result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="256">
					<text>The alteration can cause thermal instability and affect liquid load of variant subunit which is able to finally result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="256">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which can eventually result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="257">
					<text>The change can cause heat instability and affect the net charge of the varying subunit which can result in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the varying subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="257">
					<text>The alteration can result thermal instability and affect liquid charge of varying subunits which is capable of giving rise to a rapid type of electrophoretic subunit LDH-B.</text>
					<arg n="0">liquid charge of varying subunits</arg>
					<arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
				</example>
				<example src="EGRAM" no="258">
					<text>The change can result thermal instability and affect the net charge of the variant subunit which ultimately results in a fast-type electrophoretic subunit LDH-B of variant.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type electrophoretic subunit LDH-B of variant</arg>
				</example>
				<example src="EGRAM" no="258">
					<text>The change can cause thermal instability and affect the net load of the variant subunit that is observed to finally result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">the net load of the variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="259">
					<text>The alteration may cause thermal instability and affect the net load of the variant subunit which is observed to result in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">the net load of the variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="259">
					<text>The alteration can cause thermal instability and affect the net charge of the variant subunit which is observed to result in an electrophoretic subunit fast type LDH-B.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">an electrophoretic subunit fast type LDH-B</arg>
				</example>
				<example src="EGRAM" no="260">
					<text>The alteration may cause thermal instability and affect liquid load of variant subunit, which may ultimately resulted in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="260">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which may eventually have resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="261">
					<text>The alteration can cause thermal instability and affect liquid charge of varying subunits that may have resulted in a rapid type of electrophoretic subunit LDH-B.</text>
					<arg n="0">liquid charge of varying subunits</arg>
					<arg n="1">a rapid type of electrophoretic subunit LDH-B</arg>
				</example>
				<example src="EGRAM" no="261">
					<text>The change can cause heat instability and affect the net charge of the variant subunit that may have resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="262">
					<text>The alteration may cause thermal instability and affect liquid load of variant subunit which resulted in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="262">
					<text>The change can cause heat instability and affect the net charge of the variant subunit which resulted in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the variant subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="263">
					<text>The alteration can results thermal instability and affect liquid load of variant subunit which results in a variant electrophoretic subunit LDH-B fast type.</text>
					<arg n="0">liquid load of variant subunit</arg>
					<arg n="1">a variant electrophoretic subunit LDH-B fast type</arg>
				</example>
				<example src="EGRAM" no="263">
					<text>Change can cause heat instability and affect the net charge of the varying subunit results in a fast-type LDH-B electrophoretic subunit.</text>
					<arg n="0">the net charge of the varying subunit</arg>
					<arg n="1">a fast-type LDH-B electrophoretic subunit</arg>
				</example>
				<example src="EGRAM" no="264">
					<text>The research shows existence of NF-YA isoforms resulting from differential spacing.</text>
					<arg n="0">differential spacing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="264">
					<text>Research shows the existence of NF-YA isoforms resulting from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="265">
					<text>The research results existence of NF-YA isoforms that results from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="265">
					<text>Research shows the existence of isoforms of NF-YA results from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of isoforms of NF-YA</arg>
				</example>
				<example src="EGRAM" no="266">
					<text>The research shows existence of NF-YA isoforms that resulted from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="266">
					<text>Research shows the existence of isoforms of NF-YA resulted from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of isoforms of NF-YA</arg>
				</example>
				<example src="EGRAM" no="267">
					<text>These observations show that repression was the result of cooperative bonding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative bonding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="267">
					<text>These observations show that repression has been the result of cooperative binding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative binding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="268">
					<text>These observations show that repression is the result of cooperative bonding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative bonding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="268">
					<text>These observations show that repression is thought to be the result of cooperative binding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative binding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="269">
					<text>These observations show that repression is the result of cooperative binding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative binding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="269">
					<text>These observations show that repression is the result of cooperative bonding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative bonding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="270">
					<text>These observations show that repression is the result of cooperative binding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative binding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="270">
					<text>These observations show that repression is the result of cooperative bonding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative bonding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="271">
					<text>These observations show that repression can be the result of cooperative binding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative binding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="271">
					<text>These observations show that repression can be the result of cooperative bonding of the repressor to its two sites, resulting in the formation of a DNA loop.</text>
					<arg n="0">cooperative bonding of the repressor to its two sites</arg>
					<arg n="1">repression</arg>
				</example>
				<example src="EGRAM" no="272">
					<text>Two result the meaningless mutations in exon 2 (G339D and R340C), and the other three changes (one meaningless mutation, a change in table and a splicing mutation) result able to give rise to non-functional truncated proteins.</text>
					<arg n="0">the other three changes</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="272">
					<text>Two result the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) result able to give rise to non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="273">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) are result as a result in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="273">
					<text>Two are the meaningless mutations in exon 2 (G339D and R340C), and the other three changes (one meaningless mutation, a change in table and a splicing mutation) are result as a result in non-functional truncated proteins.</text>
					<arg n="0">the other three changes</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="274">
					<text>There are two mutations absent in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame mutation, and a splicing mutation) can result in non-functional truncated proteins.</text>
					<arg n="0">the other three mutations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="274">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) can result in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="275">
					<text>Two are the meaningless mutations in exon 2 (G339D and R340C), and the other three changes (one meaningless mutation, a change in table and a splicing mutation) has been result as a result in non-functional truncated proteins.</text>
					<arg n="0">the other three changes</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="275">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) has been shown to result in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="276">
					<text>There are two mutations absent in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame change and a splicing mutation) resulted in non-functional truncated proteins.</text>
					<arg n="0">the other three mutations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="276">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) have resulted in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="277">
					<text>Two are the meaningless mutations in exon 2 (G339D and R340C), and the other three changes (one meaningless mutation, a change in table and a splicing mutation) have the ability to result in non-functional truncated proteins.</text>
					<arg n="0">the other three changes</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="277">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) have the ability to result in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="278">
					<text>Two are the non-significant mutations in exon 2 (G339D and R340C), and the other three changes (one non-significant mutation, a change in table and a splicing mutation) are likely to resulting in non-functional truncated proteins.</text>
					<arg n="0">the other three changes</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="278">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) have the probability to resulting in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="279">
					<text>Two are senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) may have resulted in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="279">
					<text>There are two mutations absent in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame change and a splicing mutation) that may have resulted in non-functional truncated proteins.</text>
					<arg n="0">the other three mutations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="280">
					<text>There are two mutations absent in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame mutation, and a splicing mutation) can result in non-functional truncated proteins.</text>
					<arg n="0">the other three mutations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="280">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) can result in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="281">
					<text>There are two mutations result in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame change, and a splicing mutation) giving rise to non-functional truncated proteins.</text>
					<arg n="0">the other three mutations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="281">
					<text>Two result the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) give rise to non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="282">
					<text>There are two mutations absent in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame change and a splicing mutation) resulted in non-functional truncated proteins.</text>
					<arg n="0">the other three mutations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="282">
					<text>Two are the senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) resulted in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="283">
					<text>Two are senseless mutations in exon 2 (G339D and R340C), and the other three alterations (a meaningless mutation, a frame shift, and a splicing mutation) will result in non-functional truncated proteins.</text>
					<arg n="0">the other three alterations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="283">
					<text>There are two mutations absent in exon 2 (G339D and R340C), and the other three mutations (a meaningless mutation, a frame mutation, and a splicing mutation) will result in non-functional truncated proteins.</text>
					<arg n="0">the other three mutations</arg>
					<arg n="1">non-functional truncated proteins</arg>
				</example>
				<example src="EGRAM" no="284">
					<text>We also result the existence of NF-YA isoforms that will be derived from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="284">
					<text>We also result the the existence of NF-YA isoforms that will be derived from the differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="285">
					<text>existence of NF-YA isoforms was also reported to be able to result from differential spasms.</text>
					<arg n="0">differential spasms</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="285">
					<text>We also reported that existence of NF-YA isoforms is able to result from differential spacing.</text>
					<arg n="0">differential spacing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="286">
					<text>It has also been result that existence of NF-YA isoforms is presented as the result of differential spasms.</text>
					<arg n="0">differential spasms</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="286">
					<text>It was also result that the existence of isoforms of NF-YA is shown as a result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of isoforms of NF-YA</arg>
				</example>
				<example src="EGRAM" no="287">
					<text>It has also been reported that existence of NF-YA isoforms resulted from differential spasms.</text>
					<arg n="0">differential spasms</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="287">
					<text>It was also reported that the existence of isoforms of NF-YA had resulted from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of isoforms of NF-YA</arg>
				</example>
				<example src="EGRAM" no="288">
					<text>We also report the existence of NF-YA isoforms with the capability to result from differentiated xis.</text>
					<arg n="0">differentiated xis</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="288">
					<text>It was also reported that the existence of NF-YA isoforms had the capability to result from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="289">
					<text>We also report the existence of NF-YA isoforms result as a result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="289">
					<text>It has also been reported that the existence of NF-YA isoforms has been result as a result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">the existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="290">
					<text>We also result the existence of NF-YA isoforms that has been the result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="290">
					<text>A1 was also result (the existence of NF-YA isoforms) that has been shown to be the result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
				</example>
				<example src="EGRAM" no="291">
					<text>A1 was also reported (the existence of NF-YA isoforms) resulted from differential splicing.</text>
					<arg n="0">differential splicing</arg>
				</example>
				<example src="EGRAM" no="291">
					<text>We also reported existence of NF-YA isoforms that resulted from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="292">
					<text>We also report existence of NF-YA isoforms that has the ability to result from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="292">
					<text>We also report the existence of NF-YA isoforms that has the ability to result from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="293">
					<text>We also report existence of NF-YA isoforms that is able to result from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="293">
					<text>We also report the existence of NF-YA isoforms that is able to result from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="294">
					<text>We also report existence of NF-YA isoforms that is result as a result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="294">
					<text>We also report the existence of NF-YA isoforms that is result as a result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="295">
					<text>We also report existence of NF-YA isoforms that may have resulted from differential slicing.</text>
					<arg n="0">differential slicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="295">
					<text>We also resulted the existence of NF-YA isoforms that could have been the result of differential encryption.</text>
					<arg n="0">differential encryption</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="296">
					<text>A1 was also result (the existence of NF-YA isoforms) that can be the result of differential splicing.</text>
					<arg n="0">differential splicing</arg>
				</example>
				<example src="EGRAM" no="296">
					<text>We also result the existence of NF-YA isoforms that can be the result of differential spacing.</text>
					<arg n="0">differential spacing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="297">
					<text>We also reported existence of NF-YA isoforms that may result from differential splicing.</text>
					<arg n="0">differential splicing</arg>
					<arg n="1">existence of NF-YA isoforms</arg>
				</example>
				<example src="EGRAM" no="297">
					<text>A1 was also reported (the existence of NF-YA isoforms) that can result from differential splicing.</text>
					<arg n="0">differential splicing</arg>
				</example>
				<example src="EGRAM" no="298">
					<text>We show that the negative effect of cpxA mutation on biofilm formation may result from a decrease in the transcription of csgA coding gene csgA csgA.</text>
					<arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
					<arg n="1">the negative effect of cpxA mutation</arg>
				</example>
				<example src="EGRAM" no="298">
					<text>Let's show that the negative effect of the mutation cpxA on biofilm formation can result from a decrease in the transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="299">
					<text>negative effect of cpxA mutation in biofilm formation has been result to be the result of reduction of csgA gene transcription csgA coding.</text>
					<arg n="0">reduction of csgA gene transcription csgA coding</arg>
					<arg n="1">negative effect of cpxA mutation</arg>
				</example>
				<example src="EGRAM" no="299">
					<text>It has been result that the negative effect of the mutation cpxA in the formation of biofilm is the result of a decrease in the transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="300">
					<text>We demonstrated that negative mutation effect cpxA in the formation of biofilm resulted from reduced transcription of the csgA gene encoding for curline.</text>
					<arg n="0">reduced transcription of the csgA gene encoding for curline</arg>
					<arg n="1">negative mutation effect cpxA</arg>
				</example>
				<example src="EGRAM" no="300">
					<text>Let's show that the negative effect of the mutation cpxA in the formation of biofilms has resulted from a decrease in transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="301">
					<text>Let's show that the negative effect of the mutation cpxA in biofilm formation has the ability to result from a decrease in the transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="301">
					<text>Let's show that the negative effect of the mutation cpxA in the formation of biofilm has the ability to result from reduced transcription of the csgA gene encoding for the clinic.</text>
					<arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
					<arg n="1">negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="302">
					<text>Let's show that the negative mutation effect cpxA in the formation of biofilm is able to result from the reduced transcription of the csgA gene encoding for the clinic.</text>
					<arg n="0">reduced transcription of the csgA gene encoding for the clinic</arg>
					<arg n="1">negative mutation effect cpxA</arg>
				</example>
				<example src="EGRAM" no="302">
					<text>Let's show that the negative effect of the mutation cpxA in the formation of biofilm is able to result from a decrease in the transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="303">
					<text>Let's result that negative effect of the mutation cpxA in biofilm formation is the result of reduced transcription of the csgA curlin encoder gene.</text>
					<arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
					<arg n="1">negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="303">
					<text>Let's result that the negative effect of the mutation cpxA in biofilm formation results from a decrease in the transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="304">
					<text>We show that the negative effect of cpxA mutation on biofilm formation may have resulted from a decrease in csgA gene transcription from csglin coding.</text>
					<arg n="0">a decrease in csgA gene transcription from csglin coding</arg>
					<arg n="1">the negative effect of cpxA mutation</arg>
				</example>
				<example src="EGRAM" no="304">
					<text>Let's show that the negative effect of the mutation cpxA in biofilm formation may have resulted from a decrease in transcription of the csgA gene from csglin encoding.</text>
					<arg n="0">a decrease in transcription of the csgA gene from csglin encoding</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="305">
					<text>Let's show that the negative effect of the mutation cpxA on biofilm formation can result from a decrease in transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="305">
					<text>We show that the negative effect of cpxA mutation on biofilm formation may result from a decrease in the transcription of csgA coding gene csgA csgA.</text>
					<arg n="0">a decrease in the transcription of csgA coding gene csgA csgA</arg>
					<arg n="1">the negative effect of cpxA mutation</arg>
				</example>
				<example src="EGRAM" no="306">
					<text>We resulted that negative effect of cpxA mutation on biofilm formation was the result of reduction of csgA gene transcription csgA coding.</text>
					<arg n="0">reduction of csgA gene transcription csgA coding</arg>
					<arg n="1">negative effect of cpxA mutation</arg>
				</example>
				<example src="EGRAM" no="306">
					<text>Let's show that the negative effect of the mutation cpxA on the formation of biofilm resulted the result of a decrease in the transcription of the csgA gene encoding csgA.</text>
					<arg n="0">a decrease in the transcription of the csgA gene encoding csgA</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="307">
					<text>Let's results that negative effect of the mutation cpxA in biofilm formation is the result of reduced transcription of the csgA curlin encoder gene.</text>
					<arg n="0">reduced transcription of the csgA curlin encoder gene</arg>
					<arg n="1">negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="307">
					<text>Let's results that the negative effect of the mutation cpxA in the formation of biofilm results from a decrease in the transcription of the csgA gene from csglin encoding.</text>
					<arg n="0">a decrease in the transcription of the csgA gene from csglin encoding</arg>
					<arg n="1">the negative effect of the mutation cpxA</arg>
				</example>
				<example src="EGRAM" no="308">
					<text>It is speculated that this has been result as the result of expression of Nrf1 isoforms in mast cells.</text>
					<arg n="0">expression of Nrf1 isoforms</arg>
					<arg n="1">this</arg>
				</example>
				<example src="EGRAM" no="308">
					<text>It was result that this  has been shown as the result of the expression of isoforms of Nrf1 in mast cells.</text>
					<arg n="0">the expression of isoforms of Nrf1</arg>
					<arg n="1">this </arg>
				</example>
				<example src="EGRAM" no="309">
					<text>this is result to be the result of expression of Nrf1 isoforms in mast cells.</text>
					<arg n="0">expression of Nrf1 isoforms</arg>
					<arg n="1">this</arg>
				</example>
				<example src="EGRAM" no="309">
					<text>It was result that this  is the result of the expression of isoforms of Nrf1 in mast cells.</text>
					<arg n="0">the expression of isoforms of Nrf1</arg>
					<arg n="1">this </arg>
				</example>
				<example src="EGRAM" no="310">
					<text>We result that this is the result of expression of Nrf1 isoforms in mast cells.</text>
					<arg n="0">expression of Nrf1 isoforms</arg>
					<arg n="1">this</arg>
				</example>
				<example src="EGRAM" no="310">
					<text>It was result that this  is the result of the expression of isoforms of Nrf1 in mast cells.</text>
					<arg n="0">the expression of isoforms of Nrf1</arg>
					<arg n="1">this </arg>
				</example>
				<example src="EGRAM" no="311">
					<text>We result that this may be the result of expression of Nrf1 isoforms in mast cells.</text>
					<arg n="0">expression of Nrf1 isoforms</arg>
					<arg n="1">this</arg>
				</example>
				<example src="EGRAM" no="311">
					<text>It was result that this  may be the result of the expression of isoforms of Nrf1 in mast cells.</text>
					<arg n="0">the expression of isoforms of Nrf1</arg>
					<arg n="1">this </arg>
				</example>
			</roleset>
		</predicate>
	</framesest>
</PASBIO>